HeartSciences (HSCSW) Profit After Tax (2021 - 2026)

HeartSciences (HSCSW) has reported Profit After Tax for 6 consecutive years, with -$2.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Profit After Tax fell 31.35% year-over-year to -$2.8 million; the trailing twelve-month figure through Apr 2026 stood at -$9.3 million (down 5.54% YoY), and the FY2026 full-year result was -$9.1 million, down 4.3% from the prior year.
• Profit After Tax eased to -$2.8 million in Q2 2026 per HSCSW's latest filing, from -$2.4 million in the prior quarter.
• Across five years, Profit After Tax topped out at -$1.2 million in Q1 2022 and bottomed at -$2.8 million in Q2 2026.
• Historically, Profit After Tax has averaged -$1.9 million across 5 years, with a median of -$1.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Profit After Tax sank 213.5% in 2022, then rose 20.49% in 2023.
• Over 5 years, Profit After Tax stood at -$1.8 million in 2022, then advanced by 3.22% to -$1.7 million in 2023, then retreated by 19.13% to -$2.1 million in 2024, then retreated by 12.86% to -$2.4 million in 2025, then decreased by 17.02% to -$2.8 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$2.8 million, -$2.4 million, and -$2.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.